Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Psychopharmacology|January 1, 1989
Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteersD L Murphy, E A Mueller, J L Hill, et al.
American Journal of Medical Genetics|March 2, 1999
Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood plateletsB D Greenberg, T J Tolliver, S J Huang, et al.
Brain Research. Molecular Brain Research|January 1, 1993
Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressantsK P Lesch, C S Aulakh, B L Wolozin, et al.
Neuroendocrinology|October 1, 1988
Differential neuroendocrine responses to the 5-HT agonist m-chlorophenylpiperazine in Fawn-Hooded rats relative to Wistar and Sprague-Dawley ratsC S Aulakh, K M Wozniak, J L Hill, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
Neurotoxic and pharmacologic studies on enantiomers of the N-methylated analog of cathinone (methcathinone): a new drug of abuseM Sparago, J Wlos, J Yuan, et al.
European Journal of Pharmacology|August 14, 1991
Differential effects of long-term lithium and carbamazepine administration on Gs alpha and Gi alpha protein in rat brainK P Lesch, C S Aulakh, T J Tolliver, et al.
The Pharmacogenomics Journal|September 12, 2012
Mutations in monoamine oxidase (MAO) genes in mice lead to hypersensitivity to serotonin-enhancing drugs: implications for drug side effects in humansM A Fox, M G Panessiti, P R Moya, et al.
Psychopharmacology|August 21, 2008
Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient miceMeredith A Fox, Catherine L Jensen, Helen T French, et al.
Life Sciences|January 1, 1990
Serotonin in human lumbar cerebrospinal fluid: a reassessmentG M Anderson, I N Mefford, T J Tolliver, et al.
Archives of General Psychiatry|October 1, 1990
Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological resultsT A Pigott, M T Pato, S E Bernstein, et al.
Pageof 3